Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2023 May 25;61(5):2251512.
doi: 10.1183/13993003.51512-2022. Print 2023 May.

"Nintedanib in children and adolescents with fibrosing interstitial lung diseases." R. Deterding, L.R. Young, E.M. DeBoer, D. Warburton, S. Cunningham, N. Schwerk, K.R. Flaherty, K.K. Brown, M. Dumistracel, E. Erhardt, J. Bertulis, M. Gahlemann, S. Stowasser and M. Griese for the InPedILD trial investigators. Eur Respir J 2023; 61: 2201512

No authors listed
Published Erratum

"Nintedanib in children and adolescents with fibrosing interstitial lung diseases." R. Deterding, L.R. Young, E.M. DeBoer, D. Warburton, S. Cunningham, N. Schwerk, K.R. Flaherty, K.K. Brown, M. Dumistracel, E. Erhardt, J. Bertulis, M. Gahlemann, S. Stowasser and M. Griese for the InPedILD trial investigators. Eur Respir J 2023; 61: 2201512

No authors listed. Eur Respir J. .
No abstract available

PubMed Disclaimer

Erratum for

  • Nintedanib in children and adolescents with fibrosing interstitial lung diseases.
    Deterding R, Young LR, DeBoer EM, Warburton D, Cunningham S, Schwerk N, Flaherty KR, Brown KK, Dumistracel M, Erhardt E, Bertulis J, Gahlemann M, Stowasser S, Griese M; InPedILD trial investigators. Deterding R, et al. Eur Respir J. 2023 Feb 2;61(2):2201512. doi: 10.1183/13993003.01512-2022. Print 2023 Feb. Eur Respir J. 2023. PMID: 36041751 Free PMC article. Clinical Trial.

Publication types

LinkOut - more resources